$3.44 Billion is the total value of Flagship Pioneering Inc.'s 17 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRNA | Sell | Moderna Inc | $2,560,151,000 | +68.0% | 39,871,524 | -21.6% | 74.39% | +4.2% |
| RUBY | Rubius Therapeutics Inc | $229,013,000 | +34.4% | 38,296,526 | 0.0% | 6.65% | -16.7% | |
| DNLI | Denali Therapeutics Inc | $192,963,000 | +38.1% | 7,980,263 | 0.0% | 5.61% | -14.4% | |
| KLDO | Buy | Kaleido Biosciences Inc | $143,851,000 | +34.7% | 19,360,710 | +11.5% | 4.18% | -16.5% |
| EVLO | Buy | Evelo Biosciences Inc | $112,210,000 | +63.7% | 22,900,069 | +25.6% | 3.26% | +1.5% |
| MCRB | Seres Therapeutics Inc | $102,681,000 | +33.3% | 21,571,764 | 0.0% | 2.98% | -17.3% | |
| AXLA | Buy | Axcella Health Inc | $69,393,000 | +131.9% | 12,548,414 | +43.4% | 2.02% | +43.8% |
| SYRS | Syros Pharmaceuticals Inc | $31,324,000 | +79.8% | 2,938,494 | 0.0% | 0.91% | +11.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Flagship Ventures Fund V General Partner LLC #1
- Flagship Ventures Fund IV General Partner LLC #2
- Noubar Afeyan #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SERES THERAPEUTICS INC | 29 | Q3 2023 | 68.0% |
| DENALI THERAPEUTICS INC | 24 | Q3 2023 | 50.9% |
| SYROS PHARMACEUTICALS INC | 24 | Q2 2022 | 27.3% |
| MODERNA INC | 20 | Q3 2023 | 76.9% |
| EVELO BIOSCIENCES INC | 20 | Q1 2023 | 41.2% |
| RUBIUS THERAPEUTICS INC | 18 | Q4 2022 | 60.7% |
| Axcella Health Inc | 17 | Q2 2023 | 3.5% |
| KALEIDO BIOSCIENCES INC | 13 | Q1 2022 | 9.5% |
| Foghorn Therapeutics Inc | 12 | Q3 2023 | 6.5% |
| Sana Biotechnology Inc | 11 | Q3 2023 | 18.4% |
View Flagship Pioneering Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-09-15 |
| 4 | 2023-08-15 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-13 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-02-27 |
| 13F-HR | 2023-02-14 |
View Flagship Pioneering Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.